Hamish W. Scott

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

Journal: British journal of haematology

Published: June 20, 2026

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Journal: Blood

Published: November 04, 2025

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Journal: Blood

Published: November 04, 2025

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Journal: Blood cancer journal

Published: January 10, 2025

The role of MKK4 in T-cell development and immunity to viral infections.

The role of MKK4 in T-cell development and immunity to viral infections.

Journal: Immunology and cell biology

Published: October 28, 2019

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 23, 2015

Showing 1-6 of 6

Last Updated: 09/26/2026